These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8066489)

  • 21. Economic evaluation in health care: is there a role for cost-benefit analysis?
    Johannesson M; Jönsson B
    Health Policy; 1991 Feb; 17(1):1-23. PubMed ID: 10113574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion.
    Brouwer WB; Koopmanschap MA; Rutten FF
    Health Econ; 1997; 6(5):511-4. PubMed ID: 9353652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for quality adjustment of life years.
    Nord E
    Soc Sci Med; 1992 Mar; 34(5):559-69. PubMed ID: 1604362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assigning values to intermediate health states for cost-utility analysis: theory and practice.
    Cohen BJ
    Med Decis Making; 1996; 16(4):376-85. PubMed ID: 8912299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferences for health states: a review of measurement methods.
    Torrance GW
    Mead Johnson Symp Perinat Dev Med; 1982; (20):37-45. PubMed ID: 6927515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Welfare economics and cost-utility analysis.
    Butler JR
    Dev Health Econ Public Policy; 1992; 1():143-57. PubMed ID: 10151743
    [No Abstract]   [Full Text] [Related]  

  • 28. Ordinal preference elicitation methods in health economics and health services research: using discrete choice experiments and ranking methods.
    Ali S; Ronaldson S
    Br Med Bull; 2012 Sep; 103(1):21-44. PubMed ID: 22859714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time preference, the discounted utility model and health.
    Bleichrodt H; Gafni A
    J Health Econ; 1996 Feb; 15(1):49-66. PubMed ID: 10157428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proposal to solve the comparability problem in cost-utility analysis.
    Bleichrodt H; Herrero C; Pinto JL
    J Health Econ; 2002 May; 21(3):397-403. PubMed ID: 12022265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
    Richardson J; Khan MA; Iezzi A; Maxwell A
    Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the person trade-off a valid method for allocating health care resources?
    Pinto Prades JL
    Health Econ; 1997; 6(1):71-81. PubMed ID: 9142532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
    O'Hagan A; Stevens JW
    Health Econ; 2003 Jan; 12(1):33-49. PubMed ID: 12483759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group.
    Weinstein MC; Siegel JE; Garber AM; Lipscomb J; Luce BR; Manning WG; Torrance GW
    Health Econ; 1997; 6(5):505-10. PubMed ID: 9353651
    [No Abstract]   [Full Text] [Related]  

  • 37. Statistical issues in cost-effectiveness analyses.
    Thompson S
    Stat Methods Med Res; 2002 Dec; 11(6):453-4. PubMed ID: 12516983
    [No Abstract]   [Full Text] [Related]  

  • 38. Mapping between 6 Multiattribute Utility Instruments.
    Chen G; Khan MA; Iezzi A; Ratcliffe J; Richardson J
    Med Decis Making; 2016 Feb; 36(2):160-75. PubMed ID: 25840901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis for health communication programs.
    Guilkey DK; Hutchinson P; Lance P
    J Health Commun; 2006; 11 Suppl 2():47-67. PubMed ID: 17148099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.